Literature DB >> 169904

The effect of antiestrogens on egg yolk protein synthesis and estrogen-binding to chromatin in the rooster liver.

M Gschwendt.   

Abstract

Nafoxidine and CI-628, two well known antiestrogenic compounds, reduce the stimulating effect of estradiol on the estrogen-binding capacity of the liver chromatin from roosters. In vitro both antiestrogens compete with [3H]estradiol for the binding sites on the liver chromatin. They inhibit the estrogen-induced synthesis of egg yolk proteins (vitellogenin) and fail to induce this estrogen-specific protein synthesis by themselves. They show the ability, however, to increase the estrogen-binding sites on the liver chromatin to some extent.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 169904

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

1.  Interaction of the anti-oestrogen, nafoxidine hydrochloride, with the soluble nuclear oestradiol-binding protein in chick liver.

Authors:  C B Lazier; W S Alford
Journal:  Biochem J       Date:  1977-06-15       Impact factor: 3.857

2.  A high-affinity oestrogen-binding protein in cockerel liver cytosol.

Authors:  C B Lazier; A J Haggarty
Journal:  Biochem J       Date:  1979-05-15       Impact factor: 3.857

3.  Oestrogen-induced synthesis of thiamin-binding protein in immature chicks. Kinetics of induction, hormonal specificity and modulation.

Authors:  K Muniyappa; P R Adiga
Journal:  Biochem J       Date:  1980-01-15       Impact factor: 3.857

4.  High affinity binding of anti-oestrogen to the chick liver nuclear oestrogen receptor.

Authors:  C B Lazier; V C Jordan
Journal:  Biochem J       Date:  1982-08-15       Impact factor: 3.857

5.  3,4-bis(3'-hydroxyphenyl)hexane--a new mammary tumor-inhibiting compound. Studies on the mechanism of action on the DMBA-induced, hormone-dependent mammary tumor of the rat.

Authors:  R W Hartmann; H Schönenberger; K H Wrobel
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.